Serlife 50 mg, 100 mg Each FC tablet
PDF Leaflet Revision Date: 04 November 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of major depressive illness, OCD, and panic disorders.
Dosage (summary)
Starting dose 50 mg daily; max 200 mg for adults.
Onset of Action / Duration
Onset: 7 days, Duration: 24 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety not established; avoid breastfeeding.
Key Drug Interactions
- MAOIs
- Pimozide
- Lithium
- Warfarin
Contraindications
- Hypersensitivity
- MAOI use
- Hepatic insufficiency
- Renal insufficiency
Common side effects
- Nausea
- Insomnia
- Dizziness
- Dry mouth
Counselling Points
- Monitor for worsening symptoms
- Avoid alcohol
- Taper off to discontinue
Serious warnings
- Serotonin syndrome
- QTc prolongation
- Suicidal thoughts
Important Disclaimer
The Serlife 50 mg, 100 mg Each FC tablet professional information leaflet below is the property of Ranbaxy Pharmaceuticals {Pty) Ltd and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
